ARTICLE | Clinical News
Trerief: Ph III data
April 12, 2017 12:34 AM UTC
Top-line data from the modified intent-to-treat (mITT) population of a double-blind, Japanese Phase III trial in 351 patients with Parkinsonism accompanying dementia with Lewy bodies showed that once-...
BCIQ Company Profiles
BCIQ Target Profiles